Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Family Medicine
Clinical Trials: Diabetes Mellitus, Type 2
A listing of clinical trials currently looking for volunteers to enroll in Diabetes Mellitus, Type 2 studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Huntsville : Medical Affiliated Research Center, Inc.
Do you struggle to manage your Type 2 Diabetes?
View More »
Anniston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Anniston :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Birmingham : Research Site
AMG 151 Amgen Protocol Number 20100761
Birmingham : 1245.25.10043 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Birmingham : 1245.25.10121 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Birmingham : University of Alabama at Birmingham
Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
Birmingham : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Birmingham : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Birmingham :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Birmingham : Research Site
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Birmingham :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Birmingham : Univ Alabama At Birmingham
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Birmingham : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Dothan :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Dothan :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Dothan :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Dothan :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Gulf Shores :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Huntsville : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Huntsville : Medical Affiliated Research Center, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Huntsville : 1245.25.10037 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Huntsville : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Huntsville :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Huntsville :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Mobile : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Mobile : Wilmax Clinical Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Mobile : 1245.25.10124 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Mobile :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Mobile :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Mobile : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Montgomery : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Montgomery :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Muscle Shoals :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Muscle Shoals :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Muscle Shoals :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Muscle Shoals :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Muscle Shoals :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Ozark : Iicr, Inc. (International Institute Of Clinical Research)
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Pell City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Alaska
Little Rock : 1245.25.10015 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Pell City : 1218.74.01084 Boehringer Ingelheim Investigational Site
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
Arizona
Chandler : Radiant Research - Phoenix
Diabetes Research
Chandler : Radiant Research - Phoenix
Diabetes Research Study
Chandler : Radiant Research - Phoenix
Diabetes Research Study
Phoenix : Southwest Center for HIV/AIDS
Are You Living with HIV and Have Type 2 Diabetes?
Phoenix : Premier Research Group Limited Clinical Research Centers - Phoenix
Do you have trouble controlling your type 2 diabetes with diet and exercise and metformin? If so, this medical research study may be for you.
Tucson : Radiant Research - Tucson
Diabetes Research
Tucson : Radiant Research - Tucson
Type 2 Diabetes Research Opportunity
View More »
550 East Orange Street : Clinical Research Unit
Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans
Chandler : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Chandler : Call for Information (Investigational Site 0013)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Chandler : Investigational Site Number 840273
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Chandler :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Cottonwood :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Gilbert : Call for Information (Investigational Site 0001)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Gilbert : Call for Information (Investigational Site 0037)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Gilbert : 1245.25.10056 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Glendale : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Glendale : Investigational Site Number 840112
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Glendale :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Glendale : 1276.1.10010 Boehringer Ingelheim Investigational Site
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Glendale :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Goodyear :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Goodyear : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Goodyear :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Goodyear : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Green Valley : Eclipse Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Green Valley : Eclipse Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Green Valley : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Hot Springs : 1218.56.01002 Boehringer Ingelheim Investigational Site
Finding a Safe and Effective Dose of Linagliptin in Peadiatric Patients With Type 2 Diabetes
Mesa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Mesa : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Mesa :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Mesa : Investigational Site Number 840217
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Mesa : Investigational Site Number 840113
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Mesa :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Mesa : Clinical Research Advantage/Desert Clinical Research, LLC
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Mesa : Clinical Research Advantage Inc.
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Mesa : Mesa Family Medical Center
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Peoria : 1245.25.10175 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Phoenix : Central Phoenix Medical Clinic
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Phoenix : 43rd Medical Associates
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Phoenix : 43rd Medical Associates
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Phoenix : Hope Research Institute
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Phoenix : Call for Information (Investigational Site 0003)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Phoenix : 1245.25.10072 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Phoenix :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Phoenix : Investigational Site Number 840207
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Phoenix : Investigational Site Number 840211
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Phoenix : Investigational Site Number 840105
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Phoenix :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Phoenix :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Phoenix : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Phoenix :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Phoenix : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Phoenix : Central Phoenix Medical Clinic
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Phoenix : Stonecreek Medical Associates, Pc/Clinical Research Advantag
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Phoenix : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Tempe : Agave Clinical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Tempe : Central Phoenix Medical Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Tempe : Clinical Research Advantage/Desert Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Tempe : Clinical Research Advantage/Desert Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Tempe : Central Phoenix Medical Clinic, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Tempe : Investigational Site Number 840264
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Tempe : Investigational Site Number 840234
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Tempe : Investigational Site Number 840102
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Tempe : Investigational Site Number 840107
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Tempe :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Tucson : Visions Clinical Research - Tucson
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Tucson : Visions Clinical Research - Tucson
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Tucson : Call for Information (Investigational Site 0004)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Tucson : Research Site
AMG 151 Amgen Protocol Number 20100761
Tucson :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Tucson :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Tucson :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Tucson : Desert Sun Clinical Research, LLC
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Tucson : Desert Sun Clinical Research, LLC
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Tucson : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Tucson : Research Site
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Tucson :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Arkansas
Jonesboro : NEA Baptist Clinic - Clinical Research Center
Are you a diabetic with cardiovascular disease that has recently been hospitalized for a coronary event?
Jonesboro : NEA Baptist Clinic - Clinical Research Center
Do you have Type 2 Diabetes and high cardiovascular risk?
Little Rock : Lynn Institute of the Ozarks
Lynn Institute is currently conducting a clinical research study of an investigational medication for type 2 diabetes. For more information, please call the Lynn Institute at 501-975-2000.
View More »
Harrisburg : Harrisburg Family Medical Center
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Harrisburg :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Jonesboro : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Little Rock : Arkansas Primary Care Clinic
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Little Rock : Aureus Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Little Rock : Aureus Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Little Rock : Preferred Research Partners, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Little Rock : Research Site
AMG 151 Amgen Protocol Number 20100761
Little Rock : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Little Rock :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Little Rock :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Little Rock : Investigational Site Number 840304
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Little Rock :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Little Rock : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Little Rock :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Malvern :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Pine Bluff : Paul W. Davis, MD, Private Practice
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Pine Bluff : Paul W. Davis, MD, PA
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Searcy :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Searcy :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
White Hall :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
California
Anaheim : Anaheim Clinical Trials (ACT)
High Blood Sugar Levels can affect Your Health.
Anaheim : Anaheim Clinical Trials (ACT)
Patients with type 2 diabetes needed for a clinical research trial.
Burbank : Providence Clinical Research
Is Diabetes a
Part of Your Life?
Escondido : AMCR Institute, Inc.
A Long-Term study to determine the effect of a drug on cardiovascular events in patients with Type 2 diabetes
Escondido : AMCR Institute, Inc.
Basal Insulin Diabetes Mellitus type 2
Escondido : AMCR Institute, Inc.
Metformin Only with an Investigational Medication for Diabetes Type 2
Irvine : Irvine Center for Clinical Research
Could a potential new once-weekly type 2 diabetes medication help you find HARMONY?
Long Beach : Novo Research, Inc.
Type 2 Diabetes with inadequately controlled Hypertension
Paramount : Center for Clinical Trials, LLC
¿Es usted una persona con diabetes de tipo 2, de 30 a 70 años de edad, a la que se está tratando con metformina sola o con metformina en combinación con una sulfonilurea como gliburida (Diabeta), glipizida (Glucotrol), repaglinida (Prandin)?
Paramount : Center for Clinical Trials, LLC
¿Se le ha diagnosticado diabetes
de tipo 2?
Paramount : Center for Clinical Trials, LLC
Are you a type 2 diabetic between 30 and 70 years of age and currently being treated with either Metformin alone or Metformin in combination with Sulfonylurea such as Glyburide (Diabeta), Glipizide (Glucotrol), Repaglinide (Prandin)?
Paramount : Center for Clinical Trials, LLC
Have you been diagnosed with
Type 2 Diabetes?
Paramount : Center for Clinical Trials, LLC
Uncontrolled Blood Sugar? Take Control. Let us Help.
Sacramento : Sutter Institute for Medical Research (SIMR)
Diabetes Type 2
Sacramento : Sutter Institute for Medical Research (SIMR)
Diabetes Type 2
San Diego : Wetlin Research Associates, Inc.
Type 2 Diabetes Study
San Gabriel : California Center for Clinical Research
A study evaluating the cardiovascular outcomes in type 2 diabetic patients after a heart attack or unstable angina
Santa Ana : Research Across America
Diabetes
Santa Ana : Apex Research Institute
Diabetes Type 2 Study
Santa Ana : Coastal Multi-Specialty Research
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.
Santa Ana : Coastal Multi-Specialty Research
TECOS -DM II . A randomized, placebo controlled clinical Trial to Evaluate Cardiovascular Outcomes after treatment with Sitagliptin in patients with diabetes with inadequate glycemic control.
Walnut Creek : Diablo Clinical Research
Can you tell me about the study drug?
Walnut Creek : Diablo Clinical Research
Diabetes Shouldn’t Define You
Walnut Creek : Diablo Clinical Research
Do you have type 2 diabetes?
Walnut Creek : Diablo Clinical Research
Do you have Type 2 Diabetes? Consider Volunteering?
Walnut Creek : Diablo Clinical Research
Do you have Type 2 Diabetes? We are enrolling adult volunteers now.
Walnut Creek : Diablo Clinical Research
Do you Have Type 2 Diabetes? We are enrolling adult volunteers now.
Walnut Creek : Diablo Clinical Research
From diagnosis to decision. If you have type 2 diabetes there are a few things you should know
Walnut Creek : Diablo Clinical Research
Have you been diagnosed with Type II Diabetes?
Walnut Creek : Diablo Clinical Research
Raise your hand if you have type 2 diabetes
Walnut Creek : Diablo Clinical Research
When your type 2 diabetes is out of control, finding harmony is essential
Walnut Creek : Diablo Clinical Research
You may be eligible to join the EMERGE STUDY if you
View More »
Anaheim : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Anaheim : Orange County Research Institute
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Anaheim : Research Site
AMG 151 Amgen Protocol Number 20100761
Anaheim : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Anaheim :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Anaheim : Call for Information (Investigational Site 0082)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Anaheim : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Anaheim : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Anaheim : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Artesia :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Buena Park :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Burbank : Providence Clinical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Burlingame : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Canoga Park : Call for Information (Investigational Site 0101)
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)
Canoga Park : Call for Information (Investigational Site 0012)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Carmichael : Med Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Chino : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Chino : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Chino :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
Chino :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy
Chino :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Chino : Catalina Research Institute, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Chino : Catalina Research Institute, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Chino :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Chula Vista : Site 18
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Chula Vista : Research Site
AMG 151 Amgen Protocol Number 20100761
Chula Vista :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Chula Vista : Investigational Site Number 840005
Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes
Chula Vista : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Chula Vista : Profil Institute for Clinical Research
Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes
Chula Vista :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Clovis : Call for Information (Investigational Site 0015)
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)
Clovis : Call for Information (Investigational Site 0013)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Concord : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Concord : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Concord : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Concord : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Concord :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Concord : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Covina : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Danville : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Danville : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Danville : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Danville : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Downey :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Encino : Call for Information (Investigational Site 0008)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Encino : 1245.25.10103 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Escondido : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Escondido :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Escondido : Investigational Site Number 840244
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Escondido :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Escondido : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Fair Oaks : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Fountain Valley : Southland Clinical Research Center, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Fountain Valley : Southland Clinical Research Center, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Fountain Valley : Southland Clinical Research Center, Inc.
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Fountain Valley : Southland Clinical Research Center, Inc.
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Fresno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Fresno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Fresno : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Fresno : Research Site
AMG 151 Amgen Protocol Number 20100761
Fresno : 1245.25.10158 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Fresno : Investigational Site Number 840257
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Fresno : Research Center of Fresno
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Fresno : Valley Research
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Fresno : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Fresno : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Fresno : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Garden Grove : SC Clinical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Garden Grove :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Greenbrae : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Greenbrae : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Greenbrae : Marin Endocrine Care & Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Greenbrae : Marin Endocrine Care & Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Greenbrae : Call for Information (Investigational Site 0010)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Greenbrae : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Greenbrae : Research Site
AMG 151 Amgen Protocol Number 20100761
Greenbrae : Investigational Site Number 840213
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Greenbrae : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Greenbrae : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Greenbrae : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Greer : 1245.25.10002 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Harbor City : 1245.25.10126 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Hawaiian Gardens :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Hillsborough : Call for Information (Investigational Site 0002)
Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
Huntingdon Beach : Call for Information (Investigational Site 0001)
Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
Huntington Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Huntington Beach :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Huntington Beach : Investigational Site Number 840267
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Huntington Beach : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Huntington Beach : 1276.1.10006 Boehringer Ingelheim Investigational Site
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Huntington Beach : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Huntington Beach : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Huntington Park : Del Rosario Medical Clinic, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Huntington Park : Time Clinical Research Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Huntington Park : Time Clinical Research Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Huntington Park : Del Rosario Medical Clinic, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Huntington Park :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Huntington Park : Del Rosario Medical Clinic, Inc.
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Inglewood : Research Site
AMG 151 Amgen Protocol Number 20100761
Inglewood :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
La Jolla : Investigational Site Number 840230
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
La Jolla : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
La Jolla : Scripps Whittier Diabetes Institute
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
La Jolla : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
La Jolla : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
La Mesa : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
La Mesa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
La Mesa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
La Mesa : Investigational Site Number 840274
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
La Mesa :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Laguna Hills :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Laguna Hills : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Laguna Hills :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Lakewood : Premiere Clinical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Lakewood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Lancaster : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Lancaster : 1245.25.10001 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Lancaster : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Lincoln : Call for Information (Investigational Site 0026)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Lincoln :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Lomita : Marina Raikhel, M.D., F.A.A.F.P
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Lomita : Research Site
AMG 151 Amgen Protocol Number 20100761
Lomita :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Lomita :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Lomita : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Long Beach : Long Beach Center for Clinical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Long Beach : Premiere Clinical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Long Beach :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Long Beach : Investigational Site Number 840222
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Long Beach :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Long Beach : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Long Beach :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Long Beach : Health Care Partners Medical Group
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Long Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Long Beach : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Long Beach : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Los Angelas : David Geffen School of Medicine Division of Nephrology
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Los Angelas : UCLA Kidney Transplant Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Los Angeles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Los Angeles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Los Angeles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Los Angeles :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy
Los Angeles :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Los Angeles : Randall G. Shue, D.O.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Los Angeles : American Institute Of Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Los Angeles : Clinica Medica San Miguel
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Los Angeles : Randall G. Shue, D.O.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Los Angeles : American Institute Of Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Los Angeles : Call for Information (Investigational Site 0020)
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)
Los Angeles : Call for Information (Investigational Site 0002)
A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)
Los Angeles : Site 1
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Los Angeles : Research Site
AMG 151 Amgen Protocol Number 20100761
Los Angeles :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Los Angeles :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Los Angeles : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Los Angeles : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Los Angeles : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Los Angeles :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Los Angeles : National Research Institute
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Los Angeles : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Los Angeles : Andrew J. Lewin Medical Corporation DBA National Research Institute
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Los Angeles :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Los Angeles : Call for Information (Investigational Site 0018)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Los Angeles : Neufeld Medical Group
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Los Angeles : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Los Angeles : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Los Angeles : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Los Gatos : Office Of Richard S. Cherlin, Md
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Los Gatos : 1245.25.10047 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Los Gatos :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Merced :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Mission Hills : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Mission Hills :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Mission Viejo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Mission Viejo : Investigational Site Number 840116
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Modesto : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Monterey : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Monterey : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Moreno Valley : Spectrum Clinical Research Institute, Inc
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Moreno Valley : Spectrum Clinical Research Institute, Inc
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
National City : 1245.25.10084 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Newport Beach :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Newport Beach :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
North Hollywood :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
North Hollywood :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
North Hollywood :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Northridge : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Northridge : Diabetes Medical Center Of California
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Northridge : Diabetes Medical Center Of California
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Northridge :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Northridge : Investigational Site Number 840103
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Northridge : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Northridge : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Northridge : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Norwalk : Lucita M. Cruz,Md.,Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Norwalk : Lucita M. Cruz,Md.,Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Oceanside : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Oceanside :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Orange : Sds Clinical Trials
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Orange : Sds Clinical Trials
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Palm Desert : Research Site
AMG 151 Amgen Protocol Number 20100761
Palm Springs : Desert Oasis Healthcare Medical Group
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Palm Springs : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Palm Springs : 1245.25.10118 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Palm Springs : Investigational Site Number 840243
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Palm Springs :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Palo Alto : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Paramount : Bayview Research Group, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Paramount :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Paramount : Center for Clinical Trials, LLC.
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Paramount :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Pismo Beach :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Pismo Beach :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Pismo Beach :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Pomona :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Poway : San Diego Managed Care Group
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Poway : Call for Information (Investigational Site 0009)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Redlands : Investigational Site Number 840118
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Riverside : Apex Research of Riverside
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Riverside :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Riverside : Integrated Research Group, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Riverside : 1245.25.10061 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Roseville : Research Site
AMG 151 Amgen Protocol Number 20100761
Sacramento : River City Clinical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Sacramento : Quality Control Research, Inc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Sacramento : Quality Control Research, Inc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Sacramento : Call for Information (Investigational Site 0022)
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)
Sacramento : Sacramento Heart and Vascular Medical Associates
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Sacramento : Sacramento Heart and Vascular Medical Associates
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Sacramento :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Sacramento : Call for Information (Investigational Site 0020)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Sacramento : Perinatal And Pediatric Endocrinology
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Salinas : Diabetes Care Center
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
San Diego : Wetlin Research Associates, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
San Diego : Call for Information (Investigational Site 0021)
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)
San Diego : Call for Information (Investigational Site 0015)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
San Diego : Research Site
AMG 151 Amgen Protocol Number 20100761
San Diego : 1245.25.10040 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
San Diego : 1245.25.10055 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
San Diego : 1245.25.10193 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
San Diego :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
San Diego :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
San Diego :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
San Diego : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
San Diego : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
San Diego : Accelovance Inc.
Evaluation and Comparison of Noninvasive Blood Glucose Concentrations
San Diego : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
San Diego : Research Site
Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects
San Diego : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
San Diego : Research Site
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
San Diego : Call for Information (Investigational Site 0019)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
San Diego : Rady Children'S Hospital - San Diego
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
San Diego : Pfizer Investigational Site
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
San Dimas : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
San Dimas :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
San Francisco : Center For Clinical Research Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
San Francisco : Center For Clinical Research Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
San Francisco : Nancy J. Bohannon Med. Corp
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
San Jose : Research Site
AMG 151 Amgen Protocol Number 20100761
San Jose :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
San Mateo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
San Mateo : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
San Mateo : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
San Mateo : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
San Mateo : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Santa Ana :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
Santa Ana :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy
Santa Ana :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Santa Ana : Crest Clinical Trials, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Santa Ana : Crest Clinical Trials, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Santa Ana : Call for Information (Investigational Site 0129)
A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)
Santa Ana :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Santa Barbara : Samsun Clinic
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Santa Clarita : Clearview Medical Research, LLC
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Santa Clarita : Clearview Medical Research LLC
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Santa Monica : Orrin M. Troum, Md And Medical Associates
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Santa Monica : Orrin M. Troum, Md And Medical Associates
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Santa Rosa : 1245.25.10027 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Santa Rosa :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Spring Valley : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Spring Valley : Call for Information (Investigational Site 0006)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Spring Valley : Investigational Site Number 840250
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Spring Valley : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Spring Valley :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Spring Valley : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Stanford : Stanford University School of Medicine
Rosiglitazone-Induced Weight Gain
Stockton : 1245.25.10074 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Stockton :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Stockton :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Tarzana : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Temecula : Investigational Site Number 840209
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Temecula : Investigational Site Number 840104
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Thousand Oaks :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
Thousand Oaks :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Torrance : Torrance Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Torrance : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Torrance : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Torrence :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Tustin : Orange County Research Center
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Tustin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Tustin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Tustin : University Clinical Investigators, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Tustin : Orange County Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Tustin : Orange County Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Tustin : University Clinical Investigators, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Tustin : Investigational Site Number 840272
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Tustin : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Tustin : Orange County Research Center
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Tustin : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Valencia : 1245.25.10083 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Ventura :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Ventura : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Ventura : Ronald Chochinov Md Inc
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Ventura : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Victorville : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Vista : Cassidy Medical Group/Clinical Research Advantage
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Walnut Creek : Research Site
AMG 151 Amgen Protocol Number 20100761
Walnut Creek : Investigational Site Number 840223
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Walnut Creek :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Walnut Creek :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Walnut Creek : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Walnut Creek : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Walnut Creek : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Watsonville : Research Site
AMG 151 Amgen Protocol Number 20100761
West Hills : Infosphere Clinical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
West Hills : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
West Hills : Infosphere Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
West Hills :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
West Hills : Infosphere Clinical Research
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
West Hills : Infosphere Clinical Research
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
West Hills : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Yuba City : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Colorado
Aurora : Research Site
Weight Loss Research Study
Denver : Radiant Research - Denver Updated
Diabetes (Type 2) Research Study
Denver : Horizons Clinical Research Center, LLC
Horizons Clinical Research Center, LLC is now enrolling volunteers to participate in a clinical research study for the treatment of type 2 diabetes.
Denver : Radiant Research - Denver
Type 2 Diabetes Research Opportunity
Longmont : Longmont Medical Research Network
Research Study for Type 2 Diabetes
Longmont : Longmont Medical Research Network
Research Study for Type 2 Diabetes
View More »
Aurora : Call for Information (Investigational Site 0024)
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)
Aurora :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Aurora : University of Colorado Anschutz Medical Campus
Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes
Aurora : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Aurora : University of Colorado Anschutz Medical Campus
Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
Aurora : Research Site
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Aurora : Call for Information (Investigational Site 0023)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Colorado Springs : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Colorado Springs : Cra/Cshp
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Colorado Springs : Cra/Cshp
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Colorado Springs : 1245.25.10144 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Colorado Springs :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Colorado Springs :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Colorado Springs : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Denver : Creekside Endocrine Associates
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Denver : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Denver : Denver Internal Medicine Group
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Denver : Site 13
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Denver : 1245.25.10085 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Denver : 1245.25.10153 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Denver : University of Colorado
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Denver :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Denver : Creekside Endocrine Associates PC
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Denver :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Golden : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Littleton : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Longmont : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Connecticut
New London : Coastal Connecticut Research, LLC
Do you have Diabetes?
Waterbury : Chase Medical Research, LLC
A Randomized, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Multicenter Study, to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sulphonylurea Therapy.
Waterbury : Chase Medical Research, LLC
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB).
Waterbury : Chase Medical Research, LLC
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension treated with an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication.
Waterbury : Chase Medical Research, LLC
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Co-Administration of Sitagliptin and Atorvastatin in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin Monotherapy.
Waterbury : Chase Medical Research, LLC
A Phase III, multicentre, international, randomised, parallel group, double blind cardiovascular safety study of BI 10773 (10 mg and 25 mg administered orally once daily) compared to usual care in type 2 diabetes mellitus patients with increased cardiovascular risk.
Waterbury : Chase Medical Research, LLC
A trial comparing the efficacy and safety of insulin degludec/liraglutide and insulin degludec in subjects with type 2 diabetes. Subtitle: A 26-weeks randomised, parallel two-arm, double-blind, multi-centre, multinational, treat-to-target trial comparing fixed ratio combination of insulin degludec and liraglutide with insulin degludec in subjects with type 2 diabetes.
Waterbury : Chase Medical Research, LLC
The Effect of Dulaglutide on Major Cardiovascular Events in Patients with Type 2 Diabetes: Researching Cardiovascular Events with a Weekly Incretin in Diabetes.
View More »
Bridgeport :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Hartford :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
New Haven : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
New Haven : Research Site
Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
Norwalk : 1245.25.10066 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Stamford :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Trumbull :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Waterbury : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Waterbury : Chase Medical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Waterbury : Chase Medical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Waterbury : 1245.25.10038 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Waterbury : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Delaware
Newark : Christiana Care Health Services, Inc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Wilmington : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
District of Columbia
Florida
Aventura : South Florida Medical Research
A Phase 2B Repeat Dosing Clinical Trial of an Investigational Medication in Patients with Moderately Severe Diabetic Neuropathy
Clearwater : Clinical Research of West Florida
16 Million People in the U.S. Have Type II Diabetes. Are You One of Them?
Clearwater : Clinical Research of West Florida, Inc.
Do you have Type II Diabetes? Do you have difficulty in controlling your blood sugar levels on your current anti-diabetic medication?
Clearwater : Clinical Research of West Florida, Inc.
Type II Diabetes Research
Clearwater : Clinical Research of West Florida
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
Coral Gables : Clinical Research of South Florida
Do you have Diabetes?
Hialeah : Eastern Research
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes.
Miami : Pharmax Research Clinic, Inc.
Are you post-menopausal with low sexual desire and at risk for heart problems?
Miami : IMA Research
Clinical Trial to evaluate the safety and efficacy of a new medication in patients with Type II Diabetes with Inadequately Controlled Hypertension.
Miami : Pharmax Research Clinic, Inc.
Do you suffer from Gout and heart problems or diabetes?
Miami : IMA Research
Study #2 Clinical Trial to evaluate the safety and efficacy of a new medication in patients with Type II Diabetes with Inadequately Controlled Hypertension.
Miami : Pharmax Research Clinic, Inc.
Uncontrolled Hypertension and Diabetes Type 2
Miramar : Comprehensive Clinical Development - Miramar, FL
Individuals 18 - 65 Diagnosed with Type 2 Diabetes, ITN # 11978
Miramar : Comprehensive Clinical Development - Miramar, FL Updated
Individuals 18 to 70 years of age diagnosed with Type 2 Diabetes
Miramar : Comprehensive Clinical Development - Miramar, FL
Overweight Men and Women Including Type 2 Diabetics
Miramar : Comprehensive Clinical Development - Miramar, FL
Type 2 Diabetes
Miramar : Comprehensive Clinical Development - Miramar, FL
Type 2 Diabetes Mellitus
New Port Richey : Advanced Research Institute
A double-masked, randomized, placebo-controlled, multiple-ascending dose Phase 2 study to determine the tolerability, pharmokinetics, and pharmacodynamics of the GLP-1 receptor agonist HM11260C in adult subjects with type 2 diabetes mellitus on stable metformin therapy.
Ocala : Renstar Medical Research
Current treatment not controlling your Diabetes?
Ocala : Renstar Medical Research
Need help controlling your Type II Diabetes?
Ocala : Renstar Medical Research
Overweight with Type II Diabetes?
Ocala : Renstar Medical Research
Type II Diabetes that is not controlled by medication
Ocala : Renstar Medical Research
Uncontrolled Type II Diabetes`
St. Petersburg : Meridien Research
Type 2 Diabetes
St. Petersburg : Comprehensive Clinical Development - St. Petersburg, FL
Type II Diabetes
Tampa : Clinical Research of West Florida, Inc.
When your TYPE 2 DIABETES is out of control, finding harmony is essential.
West Palm Beach : Metabolic Research Institute, Inc.
A 22-week research study is evaluating if a new investigational insulin can provide effective and consistent blood sugar control in people with type 2 diabetes.
West Palm Beach : Palm Beach Research Center
Currently taking diabetic medication?
West Palm Beach : Metabolic Research Institute, Inc.
Do you have heart or blood vessel problems, or stroke? If you are diagnosed with Type 2 diabetes, and are over the age of 50, you may be eligible to participate in a clinical research study evaluating if the diabetes pill Sitagliptin, when taken in combination with other diabetes medication, makes a difference in heart or blood vessel problems in people with Diabetes.
West Palm Beach : Metabolic Research Institute, Inc.
If your type 2 diabetes is not controlled with your prescribed diet, exercise and diabetes medications, consider joining our clinical research study currently enrolling West Palm Beach.
View More »
Aventura : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Boca Raton :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Boca Raton : Boca Raton Clinical Research Associates, Inc.
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Boynton Beach : Zasa Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Boynton Beach : Zasa Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Boynton Beach : Investigational Site Number 840285
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Boynton Beach :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Boynton Beach : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Boynton Beach :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Boynton Beach : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Bradenton : Bradenton Research Center, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Bradenton : Bradenton Research Center, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Bradenton : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Bradenton : Research Site
AMG 151 Amgen Protocol Number 20100761
Bradenton : 1245.25.10094 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Bradenton : Investigational Site Number 840221
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Bradenton :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Bradenton : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Bradenton :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Bradenton : Pfizer Investigational Site
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
Bradenton : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Brandenton :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Brandon : PAB Clinical Research
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Brandon : PAB Clinical Research
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Brandon : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Brooksville : Research Site
AMG 151 Amgen Protocol Number 20100761
Brooksville : 1245.25.10190 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Brooksville :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Chipley : Family Care Associates Of Nw Fl
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Clearwater : Innovative Research Of West Florida, Inc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Clearwater : Innovative Research Of West Florida, Inc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Clearwater : Research Site
AMG 151 Amgen Protocol Number 20100761
Clearwater : 1245.25.10209 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Clearwater : Investigational Site Number 840233
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Clearwater :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Clearwater : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Cooper City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Cooper City : 1245.25.10212 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Cooper City :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Coral Gables :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Coral Gables : Clinical Research Of South Florida
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Coral Gables : Clinical Research Of South Florida
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Coral Gables : Site 4
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Coral Gables : Investigational Site Number 840212
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Coral Gables :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Coral Gables :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Coral Gables : Clinical Research of South Florida
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Coral Gables :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Davie :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Deland : Avail Clinical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Deland : Avail Clinical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
DeLand : Pfizer Investigational Site
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
Deland : Rankin, Bruce
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Delray Beach : 1245.25.10200 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Doral : In Vivo Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Doral : Call for Information (Investigational Site 0009)
A Study of MK-3102 in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019 AM2)
Fleming Island :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Fort Lauderdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Fort Lauderdale : S&W Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Fort Lauderdale : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Fort Myers : Research Site
AMG 151 Amgen Protocol Number 20100761
Fort Myers : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Ft Lauderdale :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Ft. Lauderdale :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Ft. Lauderdale :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Gainesville : Florida Research Network, LLC
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Gainesville : Florida Research Network, LLC
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Hallandale Beach : 1245.25.10202 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Hialeah : Palm Spring Research Institute
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Hialeah : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Hialeah : Palm Springs Research Institute
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Hialeah : The Community Research Of South Florida
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Hialeah : International Research Associates, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Hialeah : International Research Associates, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Hialeah : The Community Research Of South Florida
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Hialeah : Palm Springs Research Institute
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Hialeah : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Hialeah : 1245.25.10062 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Hialeah : 1245.25.10063 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Hialeah : Investigational Site Number 840204
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Hialeah :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Hialeah :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Hialeah :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Hialeah : Palm Springs Research Institute
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Hialeah :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Hollywood : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Hollywood : 1245.25.10033 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Hollywood : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Homestead : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Jacksonville : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Jacksonville : 1245.25.10089 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Jacksonville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Jacksonville : Investigational Site Number 840226
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Jacksonville :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Jacksonville : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Jacksonville :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Jacksonville : Jacksonville Center for Clinical Research
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Jacksonville : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Jacksonville : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Jupiter : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Kissimee :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Kissimmee : Central Florida Internists
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Kissimmee : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Kissimmee : Research Site
AMG 151 Amgen Protocol Number 20100761
Kissimmee : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Kissimmee : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Lake Mary :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Largo :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Maitland : 1245.25.10168 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Melbourne :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Melbourne : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Melbourne : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Miami : Advanced Pharma CR
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Miami : San Marcus Research Clinic, Inc.
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Miami : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Miami : Clinical Research Of Miami, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Miami : Baptist Diabetes Associates, Pa
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Miami : Community Research Foundation, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Miami : Pharmax Research Clinic, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Miami : Apf Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Miami : Clinical Research Of Miami, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Miami : Community Research Foundation, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Miami : San Marcus Research Clinic, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Miami : Baptist Diabetes Associates, Pa
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Miami : Medical Research Marseilles
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Miami : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Miami : 1245.25.10184 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Miami : 1245.25.10039 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Miami :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Miami : Novartis Investigative Site
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
Miami : Investigational Site Number 840228
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Miami : Investigational Site Number 840238
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Miami : Diabetes Research Institute
Effects of Pioglitazone on Igh-density Lipoprotein (HDL) Function in Persons With Diabetes
Miami : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Miami : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Miami : Pfizer Investigational Site
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
Miami : Pfizer Investigational Site
Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
Miami :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Miami : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Miami : International Research Associates, Llc
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Miami : Clinical Research of Miami
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Miami :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Miami : Diabetes Research Institute
Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes
Miami : Novartis Investigative Site
Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM)
Miami : Fl Clinical Research Institute, Llc
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Miami : University Of Miami
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Miami : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Miami : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Miami : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Miami Beach : Newphase Clinical Trials, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Miami Beach : Newphase Clinical Trials, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Miami Beach : NextPhase Clinical Trials, Inc.
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Miami Beach : NewPhase Clinical Trials, Inc.
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Miami Lakes : Call for Information (Investigational Site 0300)
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)
Miami Lakes : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Miami Springs : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Miami Springs : Ocean Blue Medical Research Center, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Naples :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
New Port Richey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
New Port Richey : Suncoast Clinical Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
New Port Richey : Suncoast Clinical Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
New Port Richey : Investigational Site Number 840227
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
New Port Richey :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
New Port Richey :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
New Port Richey :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
New Port Richey : Suncoast Clinical Research
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
New Port Richey : Suncoast Clinical Research
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
New Port Richey : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Ocala : Investigational Site Number 840225
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Ocala :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Ocala :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Ocala :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Ocala : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Orlanda : Compass Research
Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes
Orlando : Florida Institute For Clinical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Orlando : Florida Institute For Clinical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Orlando : Compass Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Orlando : Call for Information (Investigational Site 0003)
Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
Orlando : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Orlando : 1245.25.10123 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Orlando : 1245.25.10201 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Orlando :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Orlando : Investigational Site Number 840291
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Orlando : Investigational Site Number 840316
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Orlando :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Orlando :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Orlando :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Orlando : Arnold Palmer Hosp Ped Endocrinology Specialty Practice
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Orlando : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Ormond Beach : Ormond Medical Arts Pharmaceutical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Ormond Beach :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Oviedo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Oviedo :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Palm Harbor : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Palm Harbor : Research Site
AMG 151 Amgen Protocol Number 20100761
Palm Harbor :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Palm Harbor : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Panama City :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Pembroke Pines : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Pembroke Pines : Michele A. Morrison Internal Medicine, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Pembroke Pines : 1245.25.10025 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Pembroke Pines : 1245.25.10042 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Pembroke Pines : Investigational Site Number 840288
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Pembroke Pines : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Pembroke Pines :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Pembroke Pines :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Pembroke Pines : Pfizer Investigational Site
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
Pineallas Park :
Pharmacokinetics, Pharmacodynamics and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
Pinellas : Bellingar, Bridget
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Plant City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Plant City : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Plantation : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Plantation : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Port Charlotte : 1245.25.10147 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Port Charlotte : MEDSOL Clinical Research Center
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Port Charlotte : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Port Orange : Site 5
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Port Orange :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Port Orange : White, Alexander
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Port Orange : Hamaidan, Ammar
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Saint Petersburg : 1245.25.10203 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Saint Petersburg : 1245.25.10198 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
South Miami : South Miami Clinical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
South Miami : Pfizer Investigational Site
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
South Miami : Regenerate Clinical Trials
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
South Miami : Regenerate Clinical Trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
St. Cloud :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
St. Petersburg : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
St. Petersburg : Research Site
AMG 151 Amgen Protocol Number 20100761
St. Petersburg :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
St. Petersburg : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
St. Petersburg : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
St. Petersburg :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
St. Petersburg : Comprehensive Clinical Development, Inc.
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Stuart :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Summerfield : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Sunrise :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Sunrise :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Sunrise :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Tallahassee : Wright, Nancy
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Tampa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Tampa : Research Site
AMG 151 Amgen Protocol Number 20100761
Tampa : 1245.25.10211 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Tampa :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Tampa :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Tampa : Investigational Site Number 840251
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Tampa : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Tampa :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Tampa :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Tampa : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Trinity : Rodriguez, Daniel
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Wellington : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
West Palm Beach :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
West Palm Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
West Palm Beach : Metabolic Research Institute, Inc.
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Winter Haven : Clincal Research of Central Florida
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Winter Haven : Clinical Research of Central Florida
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Winter Haven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Winter Haven : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Winter Park : Research Site
AMG 151 Amgen Protocol Number 20100761
Georgia
Blue Ridge : River Birch Research Alliance, LLC
Do you have Type II diabetes?
Blue Ridge : River Birch Research Alliance, LLC
Have you had a heart attack or unstable angina AND also have Type II diabetes?
Columbus : Southeast Regional Research Group - Columbus
Akros- Type II Diabetes
Columbus : Southeast Regional Research Group
Type II Diabetes
Stockbridge : Clinical Research Atlanta
The Light Study
View More »
Athens : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Atlanta : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Atlanta :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
Atlanta :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy
Atlanta :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Atlanta : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Atlanta : Research Site
AMG 151 Amgen Protocol Number 20100761
Atlanta :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Atlanta : Atlanta Diabetes Associates
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Atlanta : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Atlanta : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Atlanta : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Atlanta : Atlanta Diabetes Associates
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Atlanta : Synergy Therapeutic Partners
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Atlanta : Synergy Therapeutic Partners
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Atlanta : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Atlanta : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Atlanta : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Augusta : Southern Clinical Research & Management
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Blue Ridge : River Birch Research Alliance
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Blue Ridge : River Birch Research Alliance, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Blue Ridge : River Birch Research Alliance, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Canton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Columbus : 1245.25.10174 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Columbus : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Columbus :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Decatur : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Decatur :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Decatur :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Decatur : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Decatur :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Decatur : Atlanta Pharmaceutical Research
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Decatur : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Duluth : In-Quest Medical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Duluth : In-Quest Medical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Dunwoody : Research Site
AMG 151 Amgen Protocol Number 20100761
Lawrenceville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Lawrenceville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Macon : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Marietta :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Marietta :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Perry : Middle Georgia Drug Study Center, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Perry : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Riverdale : 1245.25.10141 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Roswell : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Roswell : 1245.25.10067 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Roswell : Endocrine Research Solutions, Inc.
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Roswell : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Roswell : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Roswell :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Roswell : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Roswell : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Roswell : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Savannah :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Savannah :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Suwanee : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Tucker :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Hawaii
Honolulu : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Honolulu : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Honolulu : Site 3
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Honolulu : 1245.25.10022 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Honolulu : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
View More »
Honolulu : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Idaho
Meridian : Advanced Clinical Research, ID
Do You Need To Lose Weight and Keep It Off?
Meridian : Advanced Clinical Research, ID
Hepatitis B Vaccine Clinical Research Study
View More »
Boise : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Boise :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Eagle : Choose To Lose
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Eagle : CTL Research
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Eagle : CTL Research
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Idaho Falls : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Idaho Falls : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Idaho Falls : Call for Information (Investigational Site 0031)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Idaho Falls : Investigational Site Number 840283
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Idaho Falls : Rocky Mountain Diabetes and Osteoporosis Center
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes
Lewiston : Valley Medical Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Lewiston : Valley Medical Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Meridian : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Meridian : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Meridian : Call for Information (Investigational Site 0002)
A Study to Assess the Safety and Efficacy of MK-3102 in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)
Meridian : Call for Information (Investigational Site 0006)
Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
Meridian : Research Site
AMG 151 Amgen Protocol Number 20100761
Meridian : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Nampa :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Nampa :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Pocatello : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Illinois
Addison : Biofortis Clinical Research
Do you have uncontrolled Type 2 Diabetes?
Chicago : Research Site
Weight Loss Research Study for People with Type 2 Diabetes
Gurnee : Clinical Investigation Specialists, Inc.
Are you taking oral medication for type 2 diabetes and high blood pressure. Are your blood pressure and sugar levels still not adequately controlled?
Gurnee : Clinical Investigation Specialists, Inc.
Diabetes can be unpredictable. A clinical research study may help with type2 diabetes better manage blood glucose levels.
Gurnee : Clinical Investigation Specialists, Inc.
Do you have Type 2 Diabetes?
View More »
Arlington Heights :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Arlington Heights : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Aurora :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Burr Ridge :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Chicago : Apex Medical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Chicago : University of Chicago Medical Center
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Chicago : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Chicago : Cedar-Crosse Research Center
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Chicago : Cedar Crosse Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Chicago : Cedar Crosse Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Chicago : James R. Herron, Md, Ltd
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Chicago : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Chicago : 1245.25.10097 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Chicago :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Chicago : Investigational Site Number 840119
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Chicago : Investigational Site Number 840122
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Chicago :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Chicago :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Chicago : Cedar-Crosse Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Chicago : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Chicago : Rush University Medical Center
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Chicago : Northwestern University Medical Center
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Chicago : John Stroger Hospital of Cook County
Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia
Chicago :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Chicago : Cedar-Crosse Research Center
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Chicago : Cedar-Crosse Research Center
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Chicago : ICCT Research International, Inc.
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Chicago :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Chicago :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Chicago : Alianza Research, Inc.
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Chicago : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Chicago : University of Chicago Hospitals
The Effects of Nebivolol on Aortic Impedance Parameters in Type 2 Diabetes (The Effort Trial)
Crystal Lake : Midwest Endocrinology, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Crystal Lake : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Crystal Lake : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Evanston :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Evergreen Park : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Gurnee : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Gurnee : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Hines : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Jerseyville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
LaGrange :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
LaGrange :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Maywood : Loyola University Hospital
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
O?Fallon : So. Illinois Clin Res Ctr @ Div Of Kevin L Pritchett Md, Pc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
O?Fallon : So. Illinois Clin Res Ctr @ Div Of Kevin L Pritchett Md, Pc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Peoria : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Quincy :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Springfield : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Springfield : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Springfield : Springfield Diabetes And Endocrine Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Springfield : Springfield Diabetes And Endocrine Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Springfield :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Springfield : Investigational Site Number 840276
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Springfield : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Springfield : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Vernon Hills : Call for Information (Investigational Site 0030)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Indiana
Avon : American Health Network of IN
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Avon :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
Avon : American Health Network Of Indiana Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Avon : American Health Network Of Indiana Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Avon : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
View More »
Avon : Investigational Site Number 840314
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Avon :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Avon : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Avon : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Avon :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Avon :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Elkhart :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Elwood : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Evansville : 1245.25.10116 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Evansville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Evansville :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Evansville : Clinical Research Advantage
Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes
Franklin : American Health Network Of In Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Franklin : American Health Network Of In Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Franklin : Investigational Site Number 840317
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Franklin : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Gary : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Greenfield : American Healthcare Network of Indiana
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Greenfield :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Greenfield :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Greenfield : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Greenfield :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Greenfield : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Indianapolis : Site 17
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Indianapolis : Research Site
AMG 151 Amgen Protocol Number 20100761
Indianapolis :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Indianapolis : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Indianapolis : Indiana Clinical Research Center
Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
Indianapolis : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Indianapolis : Call for Information (Investigational Site 0003)
Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134 AM2)
Indianapolis :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Indianapolis : Research Site
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Indianapolis :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Indianapolis : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Michigan City : Laporte County Institute For Clinical Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Michigan City : Laporte County Institute For Clinical Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Michigan City : LaPorte County Institute for Clinical Research
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Michigan City : LaPorte County Institute for Clinical Research
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Mishawaka : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Muncie : American Health Network Of In Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Muncie : American Health Network Of In Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Muncie :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Muncie :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Muncie :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Muncie : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Munster : Cardiovascular Research Of Northwest Indiana, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Munster :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
New Albany : 1245.25.10109 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
New Albany :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Valparaiso : 1245.25.10206 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Iowa
Ames :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Council Bluffs :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Council Bluffs :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Council Bluffs :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Des Moines : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
View More »
Des Moines : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Iowa City : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
West Des Moines : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Kansas
Wichita : Wichita Clinic, PA
Do you have Type 2 Diabetes?
View More »
Augusta :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Kansas City :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Kansas City : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Newton :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Overland Park : Investigational Site Number 840232
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Overland Park : Investigational Site Number 840001
Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes
Overland Park :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Shawnee Mission :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Topeka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Topeka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Topeka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Topeka : Investigational Site Number 840287
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Topeka :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Topeka :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Topeka : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Topeka :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Topeka : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Wichita : 1245.25.10021 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Wichita : MidAmerica Diabetes Associates
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Wichita : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Wichita :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Wichita : Research Site
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Wichita :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Kentucky
Crestview Hills : Community Research
Type II Diabetes Research
Crestview Hills : Community Research
Type-II Diabetes
View More »
Crestview Hills : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Crestview Hills : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Elizabethtown :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Lexington : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Lexington : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Lexington : 1245.25.10186 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Lexington :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Lexington :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Lexington :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Lexington : Pfizer Investigational Site
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
Lexington : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Lexington : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Lexington : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Lexington : VA Medical Center - Lexington 596
Veterans Inpatient Insulin Study and Transition to Outpatient Therapy
Louisville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Louisville : Site 7
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Louisville : Investigational Site Number 840003
Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 Diabetes
Louisville : Pfizer Investigational Site
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
Louisville :
Pharmacokinetics, Pharmacodynamics and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
Louisville : L-MARC Research Center
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Madisonville : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Madisonville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Madisonville : 1218.74.01218 Boehringer Ingelheim Investigational Site
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
Mount Sterling : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Murray : Investigational Site Number 840231
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Owensboro :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Owensboro :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Paducah : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Paducah : 1245.25.10005 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Paducah : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Louisiana
Alexandria : Alexandria Cardiology Clinic
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Alexandria :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Alexandria : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Baton Rouge : Medical Development Centers, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Baton Rouge : Medical Development Centers, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
View More »
Baton Rouge : Woman's Hospital
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Eunice : Horizon Research Group of Opelousas
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Lafayette : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Lake Charles :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Marrero :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Metairie : Clinical Trials Management, LLC
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Metairie : Omega Clinical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Metairie : Crescent City Clinical Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Metairie : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Metairie : Research Site
AMG 151 Amgen Protocol Number 20100761
Metairie : Clinical Trials Management, LLC
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Metairie : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Metairie : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Natchitoches :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
New Orleans : 1245.25.10020 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
New Orleans :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
New Orleans : Investigational Site Number 840290
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
New Orleans :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
New Orleans :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Shreveport : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Shreveport : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Shreveport : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Shreveport : Call for Information (Investigational Site 0034)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Shreveport : LSU Shreveport
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
Slidell : Louisiana Heart Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Slidell : Louisiana Heart Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Slidell : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Slidell :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Slidell : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Slidell : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Maine
Auburn : Site 8
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Auburn : 1245.25.10012 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Auburn : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Biddeford :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Portland : Call for Information (Investigational Site 0012)
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)
View More »
Portland : Call for Information (Investigational Site 0009)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Rockport : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Rockport :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Maryland
Baltimore : Spectrum Clinical Research, Inc.
A Safety and Efficacy Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Coronary Heart Disease (CHD) Patients With a Recent Acute Coronary Syndrome (ACS) Event and Type 2 Diabetes Mellitus (T2D)
Baltimore : Spectrum Clinical Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Baltimore : Spectrum Clinical Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Towson : Spectrum Clinical Research, Inc.
A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients With Type 2 Diabetes
View More »
Balitmore :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Baltimore : Overlea Personal Physicians
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Baltimore : Overlea Personal Physicians
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Baltimore :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Baltimore :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Baltimore : MODEL Clinical Research
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Baltimore : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Baltimore : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Baltimore : University of Maryland
Smart Glucose Meter Project
Bethesda : Research Site
AMG 151 Amgen Protocol Number 20100761
College Park : 1245.25.10134 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Hyattsville : Medstar Health Research Institute
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Hyattsville : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Oxon Hill : Call for Information (Investigational Site 0045)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Oxon Hill :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Oxon Hill :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Oxon Hill :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Oxon Hill :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Oxon Hill : MD Medical Research
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Oxon Hill : MD Medical Research
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Oxon Hill :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Randallstown : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Rockville : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Rockville : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Rockville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Rockville : Investigational Site Number 840301
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Rockville : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Rockville : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Rockville : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Rockville : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Rockville : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Silver Spring : Alternative Primary Care
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Silver Spring : Alternative Primary Care
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Towson : 1245.25.10210 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Towson : IRC Clinics, Inc
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Towson : IRC Clinics, Inc
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Massachusetts
Boston : Joslin Diabetes Center
Are you having gastric bypass surgery? Do you have type 2 diabetes?
Boston : Brigham and Women's Hospital and Joslin Diabetes Center
Do you have type 2 diabetes and are ready to stop struggling with your weight? Would you consider weight loss surgery OR be willing to participate in an intensive lifestyle program?
Boston : Joslin Diabetes Center
The Brain and Nutrition Study
Boston : Joslin Diabetes Center
The SIMPLE Study: Simplified Insulin Management protocol using Lantus in Elderly
Brockton : Beacon Clinical Research
Type 2 diabetes
Haverhill : ActivMed Practices & Research, Inc.
Are you overweight? Do you also have Type 2 Diabetes or Heart Disease?
Haverhill : ActivMed Practices & Research, Inc.
Currently Looking for Patients for a TYPE II DIABETES Trial
Haverhill : ActivMed Practices & Research, Inc.
Having Trouble Managing your High Blood Sugar Readings?
Watertown : MedVadis Research Corporation
A research study to evaluate the efficacy and safety of the co-administration of sitagliptin and atorvastatin in patients with type 2 diabetes with inadequate glycemic control on metformin monotherapy
View More »
Boston : Harvard Medical School Beth Israel Deaconess Medical Center
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Boston : Brigham and Women's Hospital
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Boston :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Boston : Joslin Diabetes Center
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Brookline : Neurocare Center For Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Brookline : Neurocare, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Fall River : Genesis Clinical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Fall River :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Fall River : Investigational Site Number 840289
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Haverhill : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Haverhill : Investigational Site Number 840253
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Haverhill : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Springfield : 1245.25.10064 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Springfield :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Springfield : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Waltham : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Watertown : Atlantic Clinical Trials, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Watertown : Atlantic Clinical Trials, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Watertown : 1245.25.10051 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Worcester : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Worcester : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Michigan
Ann Arbor : ClinSite, LLC
Diagnosed with Type 2 Diabetes?
View More »
Alpena :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Alpena : Endeavor Medical Research, PLC
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Ann Arbor : The University of Michigan Health System
Evaluation of Exenatide in Patients With Diabetic Neuropathy
Ann Arbor : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Battle Creek : Associated Internal Medicine Specialists, P.C.
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Battle Creek : Associated Internal Medicine Specialists, P.C.
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Bloomfield Hills : Grunberger Diabetes Institute
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Bloomfield Hills : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Bridgman :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Buckley : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Buckley : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Buckley : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Dearborn : Call for Information (Investigational Site 0054)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Dearborn : 1245.25.10071 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Dearborn :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Dearborn : Research Site
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Dearborn : Alzohaili Medical Consultants
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Detroit :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Detroit : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Detroit : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Detroit : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Flint : Apex Medical Research MI
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Flint : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Flint : 1245.25.10013 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Flint :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Flint :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Grand Rapids : Jeffrey Vanwingen, Md
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Grand Rapids : Jeffrey Vanwingen, Md
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Kalamazoo : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Madison Heights : Investigational Site Number 840270
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Muskegon :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Novi : Providence Park Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Novi : Providence Park Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Petoskey : 1245.25.10107 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Royal Oak : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Saginaw : Saginaw Valley Medical Research Group, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Saginaw : Saginaw Valley Medical Research Group, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Saginaw :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Southfield : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Southfield : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
St. Clair Shores : Kmed Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
St. Clair Shores : Kmed Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Troy :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Troy :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Troy : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Troy : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Warren :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Ypsilanti :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Minnesota
Edina : Radiant Research - Minneapolis
Type 2 Diabetes Research Study
Edina : Radiant Research - Minneapolis
Type II Diabetes Research
View More »
Bloomington : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Duluth :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Duluth : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Eagan : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Eagan : 1245.25.10030 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Minneapolis : 1245.25.10028 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Minneapolis :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Minneapolis : International Diabetes Center
Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine
Minneapolis : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Minneapolis : International Diabetes Center
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Minneapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Minneapolis : International Diabetes Center
The Impact of Food on Blood Sugar in People With Type 2 Diabetes
Rochester : Mayo Clinic
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
Saint Paul : Pfizer Investigational Site
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
Saint Paul :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Mississippi
Biloxi : The Center For Clinical Trials
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Biloxi : The Center For Clinical Trials
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Jackson : Phillips Medical Services, Pllc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Jackson :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Olive Branch :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
View More »
Picayune : 1245.25.10176 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Picayune :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Picayune :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Missouri
Kansas City : Dynamic Clinical Research, Inc.
A 16-week, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to compare the safety and efficacy of Starlix (nateglinide) vs. placebo in patients with type 2 diabetes who are inadequately controlled with basal insulin glargine in combination with metformin and/or thiazolidinedione (pioglitazone or rosiglitazone)
Kansas City : Dynamic Clinical Research, Inc.
A Multi-center, Randomized, Open-label, Active Controlled, Parallel Arm Study to Compare the Efficacy of 12 Weeks of Treatment with Vildagliptin 100mg, qd to Thiazolidinedione (TZD) as Add-on Therapy in Patients with type 2 Diabetes Inadequately Controlled with Metformin Monotherapy in a Community-based Practice Setting
Kansas City : Dybedal Clinical Research Center
Title: Protocol MB102077: A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapagliflozin in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication
St. Louis : Washington University in St. Louis - Center for Clinical Studies
A Washington University Vitamin D Research Study Seeks Volunteers with Type 2 Diabetes.
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Are you down in the dumps with your diabetes?
St. Louis : Radiant Research - St. Louis
Diabetes Research
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Do you have type 2 diabetes and coronary artery disease?
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Pre-diabetes: Are you at risk?
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Type 2 diabetes study seeks participants 10 – 25 years old.
View More »
Chesterfield : 1245.25.10011 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Chesterfield :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Chesterfield : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Chesterfield : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Chesterfield : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Columbia : 1245.25.10112 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Columbia : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Columbia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Jefferson City : Jefferson City Medical Group
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Jefferson City : Jefferson City Medical Group
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Jefferson City : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Kansas City : Clinical Research Consultants (MO)
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Kansas City : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Kansas City : Kcumb Dybedal Clinical Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Kansas City : Call for Information (Investigational Site 0001)
A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)
Kansas City : 1245.25.10163 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Kansas City :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Kansas City : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Kansas City : Kansas City Children's/Childrens Mercy
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
Kansas City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Kansas City : The Center for Pharmaceutical Research, P.C.
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
St Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
St Peters :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
St. Charles : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
St. Charles : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
St. Joseph :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
St. Louis : St. Louis Center For Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
St. Louis : Research Site
AMG 151 Amgen Protocol Number 20100761
St. Louis :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
St. Louis : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
St. Louis : Washington University
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
St. Louis :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
St. Louis :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
St. Louis : St. Louis Children'S Hospital
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Montana
Billings : Montana Health Research Institute, Inc.
Do you have diabetes?
View More »
Billings : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Billings : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Billings : Investigational Site Number 840115
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Billings : Billings Clinic Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Billings : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Billings : Billings Clinic Updated
Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese
Billings : Billings Clinical Research Center
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Butte : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Butte : Big Sky Clinical Research
Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes
Great Falls : 1245.25.10148 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Great Falls : 1245.25.10191 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Great Falls :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Great Falls : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Kalispell : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Kansas City : Kcumb Dybedal Clinical Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Missoula : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Nebraska
Fremont :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Lincoln : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Lincoln : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Lincoln : Call for Information (Investigational Site 0025)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
North Platte : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
View More »
Ohama : Icon Clinical Pharmacology
Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy Participants
Omaha : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Omaha : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Omaha : 1245.25.10205 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Omaha : 1245.25.10034 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Omaha :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Omaha :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Omaha :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Omaha : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Omaha :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Omaha : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Omaha : Research Site
Single Ascending Dose Trial in Patients With Type 2 Diabetes
Omaha : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Omaha : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Nevada
Las Vegas : AB Clinical Trials
Do you have Type II Diabetes?
View More »
Henderson : Clinical Research Advantage
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Henderson : Clin Research Advantage, Inc. James Meli, Do Family Pracice
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Henderson : Clin Research Advantage, Inc. James Meli, Do Family Pracice
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Henderson : Desert Endocrinology Clinical Research Center-Henderson
Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes
Henderson : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Henderson : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Las Vegas : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Las Vegas : Ab Clinical Trials
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Las Vegas : Clinical Research Advantage, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Las Vegas : Office Of Ted Thorp, Md
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Las Vegas : Palm Medical Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Las Vegas : Independent Clinical Researchers@ Wolfson Medical Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Las Vegas : Palm Medical Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Las Vegas : Clinical Research Advantage, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Las Vegas : Independent Clinical Researchers@ Wolfson Medical Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Las Vegas : Office Of Ted Thorp, Md
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Las Vegas : Site 9
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Las Vegas : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Las Vegas :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Las Vegas : Investigational Site Number 840201
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Las Vegas : Investigational Site Number 840256
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Las Vegas : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Las Vegas :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Las Vegas : Nevada Alliance Against Diabetes
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Las Vegas : 1276.1.10007 Boehringer Ingelheim Investigational Site
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Las Vegas :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Las Vegas : Alliance Against Diabetes/AAD Clinical Research
Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes
Las Vegas : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Reno : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Reno : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Reno : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
New Hampshire
Newington : ActivMed Practices & Research, Inc. NH
Currently Looking for Patients for a TYPE II DIABETES Trial
View More »
Nashua : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Nashua : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Nashua : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Nashua : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Nashua : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Nashua : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Newington : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
New Jersey
Edison : Anderson & Collins Clinical Research, Inc.
At Risk for Type 2 DIABETES?
Toms River : Physicians Research Center, LLC
6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus both in combination with oral antihyperglycemic drug in Patients with Type 2 Diabetes Mellitus with a 6 month Safety Extension Period.
Toms River : Physicians Research Center, LLC
The effect of insulin degludec in combination with liraglutide and metformin in subjects with type 2 diabetes qualifying for treatment intensification
View More »
Berlin : Comprehensive Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Berlin :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Berlin :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Berlin : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Blackwood : 1245.25.10194 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Brick : Libra Clinical Research Associates
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Bridgewater :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Camden :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Camden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Denville : North Jersey Endocrine Consultants, LLCAND
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Elizabeth : Central Jersey Medical Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Elizabeth : Call for Information (Investigational Site 0001)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Elizabeth :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Elizabeth :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Elizabeth :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Flemington : 1245.25.10014 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Flemington : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Hackensack : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Haddon Heights :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Haddon Heights :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Haddon Heights : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Hamilton : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Hamilton : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Lawrenceville : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Lawrenceville : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Lawrenceville : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Lawrenceville : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Linden :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Livingston : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Lyons : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Margate : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Mine Hill :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
New Brunswick :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Newark :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Sea Girt : Investigational Site Number 840203
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Sea Girt : Investigational Site Number 840101
Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
Sicklerville : Investigational Site Number 840295
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
South Plainfield :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Toms River : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Toms River : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Toms River :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
Toms River : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Toms River : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Toms River : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Trenton : Site 26
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Union : 1276.1.10015 Boehringer Ingelheim Investigational Site
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Wall : Call for Information (Investigational Site 0127)
A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)
New Mexico
Albuquerque : Albuquerque Clinical Trials, Inc.
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Albuquerque :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Albuquerque : Investigational Site Number 840269
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Albuquerque : Albuquerque Clinical Trials
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Albuquerque : University of New Mexico Clinical and Translational Science Center
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
View More »
Albuquerque : Albuquerque Clinical Trials
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Santa Fe : Regional Endocrinology Associates, PC
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
New York
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
Central Mechanisms that Regulate Glucose Metabolism in Humans
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
Closed Loop System in Type 1 Diabetes Management Comparison with Pramlintide vs Exenatide
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
Sitagliptin Dose Determination Study in Type 1 Diabetes
Bronx : Biomedical Research Alliance of New York
Type 2 Diabetes and Overt Nephropathy
Bronx : Biomedical Research Alliance of New York
Type 2 Diabetes Mellitus and Cardiovascular Outcomes - Adults
Lake Success : Biomedical Research Alliance of New York
Clinical trial to test how different doses of a study drug can help people with Type 2 Diabetes
Mineola : Winthrop University Hospital Clinical Trials Center
Diabetes - Type 2 Diabetes Mellitus
Mineola : Winthrop University Hospital Clinical Trials Center
Type 2 Diabetes
Mineola : Winthrop University Hospital Clinical Trials Center
Type 2 Diabetes - patients after an Acute Coronary Syndrome
Mineola : Winthrop University Hospital Clinical Trials Center
Type 2 Diabetes and Cardiovascular Disease
View More »
(151A) Northport : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Albany : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Albany : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Albany : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Albany : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Binghamton : 1245.25.10131 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Bronx : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Bronx :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Bronx : Albert Einstein College of Medicinie
Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
Bronx : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Brooklyn : Call for Information (Investigational Site 0021)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Buffalo : Women And Children'S Hopsital Of Buffalo
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Endwell : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Freash Meadows : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Glen Falls :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Huntington :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Kingston :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Manlius : Central New York Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Mineola : Research Site
AMG 151 Amgen Protocol Number 20100761
Mineola : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Mineola : Research Site
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Mineola : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
New Hyde Park : North Shore Diabetes & Endocrine Assoc.
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
New Hyde Park : North Shore Diabetes and Endocrine Associates
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New Windsor :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
New York : The Rogosin Institute
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
New York : Medex Healthcare Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
New York : Medex Healthcare Research, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
New York :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
New York :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
New York : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
New York : MedHex Health
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New York : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
New York : Weill Cornell Medical College
Roux-en-Y-Gastric Bypass vs. Lifestyle Modification and Medical Therapy in the Treatment of Type 2 Diabetes
New York : Novartis Investigative Site
Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
North Massapequa : Digiovanna Institute For Medical Education & Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
North Massapequa : Digiovanna Institute For Medical Education & Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
North Massapequa : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Northport : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Rochester : Call for Information (Investigational Site 0014)
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170 AM1)
Rochester : Site 12
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Rochester : 1245.25.10029 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Rochester :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Rochester :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Rochester : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Rochester : Call for Information (Investigational Site 0011)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Rosedale : Clinical Research Development Associates (NY)
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Rosedale :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Rosedale : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Saratoga Springs :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Sleepy Hollow : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Smithtown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Smithtown : 1245.25.10142 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Smithtown : Endocrine Associates of Long Island, PC
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Smithtown : Middle Country Endocrinology, P.C.
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Smithtown : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Smithtown : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Springfield Gardens :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Staten Island : Call for Information (Investigational Site 0035)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Staten Island : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Staten Island : 1245.25.10096 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Staten Island : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Valhalla :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
West Seneca : Southgate Medical Group
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
West Seneca : Southgate Medical Group
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
West Seneca : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
West Seneca : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
West Seneca : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Westfield : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Williamsville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
North Carolina
Cary : PMG Research of Cary
Type II Diabetics on Oral Diabetes Medications and Insulin
Charlotte : PMG Research of Charlotte
Diabetes: Are you a diabetic and concerned about heart disease?
Charlotte : PMG Research of Charlotte
Do you have type 2 diabetes that is being treated with metformin?
Charlotte : PMG Research of Charlotte
Type 2 Diabetes Study for Patients Not Currently Taking Diabetes Medications
Charlotte : American Health Research
Type 2 Diabetes Trial for patients taking more than 1500 mg of Metformin daily
Hickory : PMG Research of Hickory
Cardiovascular Outcomes Study For Patients With Type 2 Diabetes
Hickory : PMG Research of Hickory
DIABETES: Do you have Type 2 Diabetes?
Hickory : PMG Research of Hickory
Diabetes: Type II Diabetes and Heart or Vascular Disease?
Hickory : PMG Research of Hickory
Do you have Type 2 Diabetes?
Hickory : PMG Research of Hickory
Do you use insulin for your Type II Diabetes?
High Point : High Point Clinical Trials Center
Type 2 Diabetic Research Study
Raleigh : Multi-Specialty Research Associates of NC
Are you a diabetic patient taking medicine to treat your high cholesterol?
Raleigh : Multi-Specialty Research Associates of NC
Are you on insulin and suffer from Type 2 diabetes?
Raleigh : PMG Research of Raleigh
Cardiovascular Outcomes Study For Patients With Type 2 Diabetes
Raleigh : PMG Research of Raleigh
Diabetes: Do You Have Type 2 Diabetes?
Raleigh : Multi-Specialty Research Associates of NC
Do you suffer from Type 2 diabetes?
Raleigh : PMG Research of Raleigh
Type 2 Diabetes Research Study for people who have had a recent
ACS (Acute Coronary Syndrome) event such as heart attack or unstable angina
Salisbury : PMG Research of Salisbury
Cardiovascular Outcomes Study For Patients With Type 2 Diabetes
Salisbury : PMG Research of Salisbury
Diabetes: Do You Have Type 2 Diabetes?
Salisbury : PMG Research of Salisbury
Do you have Type 2 diabetes?
Salisbury : PMG Research of Salisbury
Type II Diabetes Research Study
Wilmington : PMG Research of Wilmington
Cardiovascular Outcomes Study For Patients With Type 2 Diabetes
Wilmington : PMG Research of Wilmington
Do you have Type 2 Diabetes?
Wilmington : PMG Research of Wilmington
Do you use insulin for your Type II Diabetes?
Wilmington : PMG Research of Wilmington
Type 2 Diabetes Research Study for people who have had a recent
ACS (Acute Coronary Syndrome) event such as heart attack or unstable angina
Wilmington : PMG Research of Wilmington
Type II Diabetes Research Study
Winston Salem : PMG Research of Winston-Salem
Diabetes Research Study
Winston Salem : PMG Research of Winston-Salem
Do you use insulin for your Type II Diabetes?
Winston Salem : PMG Research of Winston-Salem
Type II Diabetes Research Study
Winston-Salem : PMG Research of Winston-Salem
Being treated for Type 2 Diabetes, but not controlled yet?
Winston-Salem : PMG Research of Winston-Salem
Diabetes: Are you a diabetic and concerned about heart disease?
Winston-Salem : PMG Research of Winston-Salem
Diabetes: Are you having trouble managing your diabetes?
Winston-Salem : PMG Research of Winston-Salem
Do you have Type 2 Diabetes?
Winston-Salem : PMG Research of Winston-Salem
Getting Your Diabetes Under Control is job Number One!
Winston-Salem : PMG Research of Winston-Salem
Would you like to participate in a Diabetes study?
View More »
Asheville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Asheville : Investigational Site Number 840247
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Ashville : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Burlington : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Burlington : 1245.25.10196 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Calabash : 1245.25.10207 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Calabash :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Calabash :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Chapel Hill : University of North Carolina School of Medicine
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Chapel Hill : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Charlotte : Pmg Research Of Charlotte
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Charlotte : Barat Research Group, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Charlotte :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Charlotte :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Charlotte :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Charlotte :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Charlotte : PMG Research of Charlotte
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Charlotte : PMG Research of Charlotte
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Charlotte :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Durham : 1245.25.10053 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Durham : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Durham : Diabetes Care Center
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Durham :
Pharmacokinetics, Pharmacodynamics and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
Durham :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Durham : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Forsyth :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Greensboro : Call for Information (Investigational Site 0021)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Greensboro : Call for Information (Investigational Site 0011)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Greensboro : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Greensboro :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Greensboro :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Greensboro : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Greensboro : PharmQuest
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Greensboro : PharmQuest
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Greensboro :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Greensboro : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Greensboro : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Greenville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Greenville : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Greenville : 1245.25.10010 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Greenville : Physicians East, PA
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Hickory : Clinical Trials of America Inc
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Hickory : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Hickory :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Jacksonville : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Lenoir : Call for Information (Investigational Site 0016)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Lenoir :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Lenoir : 1276.1.10002 Boehringer Ingelheim Investigational Site
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Mooresville :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Mooresville :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Mooresville :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Morehead : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Morehead City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Morehead City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Morehead City : Diabetes & Endocrinology Consultants
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Morehead City :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Morehead City : Diabetes & Endocrinology Consultants
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Morehead City : Down East Medical Associates
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Morehead City :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Morehead City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Morehead City : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Morehead City : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Morganton : Burke Primary Care
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Morganton : Burke Primary Care
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Morganton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Morganton :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Morganton :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Morganton :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Raleigh : Research Site
AMG 151 Amgen Protocol Number 20100761
Raleigh :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Raleigh :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Raleigh : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Raleigh :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Rocky Mount : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Salisbury : Crescent Medical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Salisbury : Pmg Research Of Salisbury
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Salisbury : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Salisbury : PMG Research of Salisbury
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Shelby : Carolina Research Center
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Smithfield :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Statesville : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Statesville : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Tabor City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Tabor City : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Wilmington : Pmg Research Of Wilmington Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Wilmington : INC Research
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
Wilmington : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Wilmington :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Wilmington : New Hanover Medical Research
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Winston-Salem : 1245.25.10188 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Winston-Salem :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Winston-Salem :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Winston-Salem : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Winston-Salem :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Winston-Salem : Piedmont Medical Research, LLC.
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
North Dakota
Bismarck : Legacy Pharma Research
Type 2 Diabetes and Acute Coronary Syndrome
View More »
Bismarck : Research Site
AMG 151 Amgen Protocol Number 20100761
Bismarck :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Fargo : Lillestol Research
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Fargo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Fargo : Lillestol Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Fargo : Lillestol Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Fargo : Research Site
AMG 151 Amgen Protocol Number 20100761
Minot :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Ohio
Cincinnati : Community Research
Taking Insulin for your Type-II Diabetes
Cincinnati : Community Research
Taking Metformin alone or in combination for your Type-II Diabetes?
Cincinnati : Community Research
Type 2 Diabetes
Cincinnati : Community Research
Type-II Diabetes
Cincinnati : Community Research
Type-II Diabetes & High Blood Pressure
Cincinnati : Community Research
Type-II Diabetes & High Blood Pressure
Cleveland : Rapid Medical Research, Inc. (RMR)
Are you a Type 2 Diabetic taking metformin but still struggle to achieve adequate blood sugar levels?
Cleveland : Rapid Medical Research, Inc. (RMR)
Do You Need To Lose Weight and Keep It Off?
Cleveland : Rapid Medical Research, Inc. (RMR)
Hepatitis B Vaccine Clinical Research Study
Cleveland : Rapid Medical Research, Inc. (RMR)
If you’re a Type 2 Diabetic, take at least 1 dose of insulin per day and struggle to achieve adequate blood sugar levels, you may be interested in this clinical research study.
Cleveland : Rapid Medical Research, Inc. (RMR)
Type II Diabetes & Cardiovascular Disease
Columbus : Columbus Clinical Research
Diabetes
Columbus : Ohio State University
Fatty Acids as Complementary Therapy (FACT)
Dayton : Providence Health Partners - Center for Clinical Research
Type II Diabetes - Diet Controlled
Dayton : Providence Health Partners - Center for Clinical Research
Type II Diabetes on Single or Multiple Medications
View More »
Akron :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Akron : Call for Information (Investigational Site 0014)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Akron : Akron Children'S Hospital
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Athens :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Athens : Ohio University College Of Osteopathic Medicine
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Beavercreek : Clinical Inquest Center, Ltd.
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
Beavercreek : Clinical Inquest Center, Ltd.
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Beavercreek : Clinical Inquest Center, Ltd.
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Canal Fulton : Call for Information (Investigational Site 0090)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Canton : Clinical Research Limited
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Canton : Clinical Research Limited
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Carlisle :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Cincinnati : Community Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Cincinnati : Community Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Cincinnati : Site 14
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Cincinnati : Research Site
AMG 151 Amgen Protocol Number 20100761
Cincinnati : 1245.25.10086 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Cincinnati : 1245.25.10060 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Cincinnati :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Cincinnati :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Cincinnati : Pfizer Investigational Site
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
Cincinnati :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Cincinnati : Novartis Investigative Site
Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
Cincinnati :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Cincinnati : The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital
Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes
Cincinnati : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Cincinnati : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Cincinnatti : Gottschlich, Gregory
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Cleveland : Research Site
AMG 151 Amgen Protocol Number 20100761
Cleveland : 1218.74.01206 Boehringer Ingelheim Investigational Site
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
Cleveland :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Cleveland : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Cleveland : GSK Investigational Site
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus
Cleveland :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Columbus : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Columbus : Investigational Site Number 840307
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Columbus : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Dayton : Research Site
AMG 151 Amgen Protocol Number 20100761
Dayton : 1245.25.10137 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Dayton :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Dayton : Providence Health Partners - Center for Clinical Reseach
Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes
Dayton : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Dayton : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Delaware : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Delaware : 1245.25.10138 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Delaware :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Franklin : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Franklin : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Franklin : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Franklin : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Gallipolis : Call for Information (Investigational Site 0002)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Gallipolis : Call for Information (Investigational Site 0007)
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018 AM1)
Kettering : Wells Institute For Health Awareness
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Kettering : Wells Institute For Health Awareness
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Kettering : Call for Information (Investigational Site 0014)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Kettering : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Kettering : Research Site
AMG 151 Amgen Protocol Number 20100761
Kettering : 1245.25.10156 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Kettering : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Kettering :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Kettering :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Lorain :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Lyndhurst :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Marion :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Marion :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Mason : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Mason : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Maumee :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Maumee :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Maumee :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Mentor : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Middleburg Heights : Cleveland Sleep Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Middleburg Heights : Cleveland Sleep Research Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Middleburg Heights :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Munroe Falls :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Perrysburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 Diabetes
Perrysburg : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Perrysburg : Clinical Research Source, Inc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Perrysburg : Call for Information (Investigational Site 0013)
A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Springfield :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Toledo :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Toledo : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Toledo : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Toledo : University of Toledo/Promedica
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
Toledo : Call for Information (Investigational Site 0096)
Study to Assess Safety & Efficacy of Sitagliptin as Initial Monotherapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants (MK-0431-083)
Wadsworth : Family Practice Center Of Wadsworth, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Wadsworth : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Wadsworth :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Wadsworth :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Willoughby Hills : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Willoughby Hills :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Zanesville : 1245.25.10192 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Zanesville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Oklahoma
Oklahoma City : Harold Hamm Diabetes Center at the University of Oklahoma - Clinical Trials Unit
The Harold Hamm Diabetes Center in Oklahoma City, OK is looking for volunteers diagnosed with type 2 diabetes and inadequate blood sugar control, currently taking Metformin only, to participate in a research study evaluating the effectiveness and safety of an investigational combination of approved medications.
Oklahoma City : Harold Hamm Diabetes Center at the University of Oklahoma - Clinical Trials Unit
The Harold Hamm Diabetes Center in Oklahoma City, OK is looking for volunteers diagnosed with type 2 diabetes and moderate renal (kidney) impairment to participate in a research study evaluating the effectiveness and safety of an investigational combination formula.
Tulsa : Vital Prospects Clinical Research Institute, P.C.
Have HIGH BLOOD PRESSURE and DIABETES TYPE II? We need your help in a study to evaluate the efficacy and safety of Aliskiren administered in combination with Valsartan versus Valsartan alone.
View More »
Bartlesville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Norman : Lynn Institute of Norman
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Norman : Research Site
AMG 151 Amgen Protocol Number 20100761
Norman : 1245.25.10114 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Norman : Investigational Site Number 840229
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Norman :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Norman :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Oklahoma City : Paradigm Research Professionals, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Oklahoma City : Integris Family Care Central
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Oklahoma City : Sooner Clinical Research
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Oklahoma City : Call for Information (Investigational Site 0005)
Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
Oklahoma City : Research Site
AMG 151 Amgen Protocol Number 20100761
Oklahoma City :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Oklahoma City :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Oklahoma City :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Oklahoma City : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Oklahoma City :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Oklahoma City : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Oklahoma City : Infinity Research Group, LLC
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Oklahoma City : Infinity Research Group, LLC
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Oklahoma City :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Oklahoma City :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Oklahoma City : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Tulsa :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Yukon : Integris Family Care Yukon
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Yukon : Integris Family Care Yukon
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Yukon :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Oregon
Eugene : Clinical Trials of America, Inc
Millions of people struggle to manage their Type 2 Diabetes
Are you one of them ?
View More »
Ashland : Call for Information (Investigational Site 0004)
Addition of MK-3102 to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
Bend :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Corvallis :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Eugene : Willamette Valley Clinical Studies
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Eugene : Willamette Valley Clinical Studies
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Eugene : 1245.25.10082 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Eugene :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Eugene :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Gresham : Cyn3rgy Research
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes
Portland :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Portland :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Portland : Oregon Health & Science University
Effects of DPP-4 Inhibition on Triglycerides
Portland : Oregon Health and Science University
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
Portland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Portland :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Pennsylvania
Altoona : Blair Medical Associates, Inc. Clinical Trials Dept.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Altoona : Blair Medical Associates, Inc. Clinical Trials Dept.
Canakinumab
Altoona : Blair Medical Associates, Inc. Clinical Trials Dept.
Exenatide
Lancaster : Research Across America
Type II Diabetes Weight Loss Study
Reading : Research Across America
Type II Diabetes Weight Loss Study
View More »
Altoona :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
Altoona :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Altoona : Call for Information (Investigational Site 0128)
A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)
Altoona :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Altoona : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Altoona : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Beaver : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Bethlehem : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Broomall : Southeastern Pa Medical Institute
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Broomall : Southeastern Pa Medical Institute
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Camp Hill : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Clairton : 1245.25.10154 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Erie : Westminster Family Medicine
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Feasterville : Abington Memorial Hos/Feasterville Family Health Care Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Feasterville : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Feasterville Trevose : Abington Memorial Hos/Feasterville Family Health Care Center
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Feasterville Trevose : 1245.25.10052 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Fleetwood : Integrated Medical Group Pc / Fleetwood Medical Assoc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Fleetwood : 1245.25.10069 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Fleetwood :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Greensburg : 1245.25.10172 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Harleysville :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Harleysville :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Harleysville :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Hershey : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Indiana : 1245.25.10050 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Jenkintown : The Clinical Trial Center, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Jenkintown : The Clinical Trial Center, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Johnstown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Lancaster :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Landsdale : Detweiler Family Practice
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Landsdale : Detweiler Family Practice
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Langhorne :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Langhorne : Alan B. Schorr, DO FACE
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting
Lansdale : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Lansdale : 1245.25.10009 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Lansdale : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Lansdale :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Levittown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Levittown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Levittown :
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Levittown :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Newport : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Norristown : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Philadelphia : Arcuri Clinical Research Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Philadelphia : Philadelphia Health Associates - Adult Medicine
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Philadelphia : Arcuri Clinical Research Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Philadelphia : Philadelphia Health Associates - Adult Medicine
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Philadelphia : Novo Nordisk Clinical Trial Call Center
A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin
Philadelphia : 1245.25.10214 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Philadelphia : University of Pennsylvania Center for Weight and Eating Disorders
Blood Glucose Stability and Variability on Two Diets
Philadelphia :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Philadelphia :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Philadelphia : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Philadelphia : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Philadelphia : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Philadelphia :
Pharmacokinetics, Pharmacodynamics and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
Philadelphia : Children's Hospital of Philadelphia
PK Study of Dapagliflozin in Pediatric Subjects With T2DM
Philadelphia : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Philadelphia : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Pittsburg : 1245.25.10173 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Pittsburgh : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
Pittsburgh : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Participants With Type 2 Diabetes Mellitus
Pittsburgh : 1245.25.10149 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Pittsburgh : 1245.25.10197 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Pittsburgh :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Pittsburgh : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Pittsburgh : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Pittsburgh : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and Metformin Therapy
Pottstown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Reading : Research Across America
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Reading : Research Across America
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Schwenksville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Scotland :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Scottdale : 1245.25.10159 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Scranton :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone
Sellersville :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Tipton :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Tipton : 1245.25.10162 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Tipton : Investigational Site Number 840308
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Tipton : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Uniontown : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Uniontown : Preferred Primary Care Physicians
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Uniontown : Pish Medical Associates
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Uniontown : Pish Medical Associates
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Uniontown : Preferred Primary Care Physicians
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Uniontown : 1245.25.10146 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Uniontown :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Uniontown :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Upper Darby : The Chandler & Thakur Medical Group
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Upper Darby : The Chandler & Thakur Medical Group
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Upper St Clair : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Upper St Clair : Novo Nordisk Clinical Trial Call Center
The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes
Yardley :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Rhode Island
East Providence :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
East Providence : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Pawtucket : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Warwick : Greater Providence Clinical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Warwick : Greater Providence Clinical Research, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
South Carolina
Anderson : Internal Medicine Associates of Anderson, P.A.
New Investigational Medication Study for Patients with Type 2 Diabetes and Increased Cardiovascular Risks
Mt Pleasant : PMG Research of Charleston
Cardiovascular Outcomes Study For Patients With Type 2 Diabetes
View More »
Aiken : C.S.R.A. Renal Services
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Anderson : Southeastern Research Associates, Inc.
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Anderson : 1245.25.10070 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Beaufort : Lowcountry Medical Group, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Beaufort : Lowcountry Medical Group, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
Charleston : Pharmacorp Clinical Trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Charleston : Medical Research South
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Charleston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
Charleston : 1245.25.10044 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Charleston : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
Charleston : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Clinton : 1245.25.10129 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Columbia : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Columbia : Novo Nordisk Clinical Trial Call Center
Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
Columbia :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Florence :
Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
Greenville : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Greenville :
Colesevelam Pediatric Type 2 Diabetes Mellitus Study
Greenville : Upstate Pharmaceutical Research
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Greer : Mountain View Clinical Research
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
Greer : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Greer :
A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin Therapy
Greer :
A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy
Greer : Investigational Site Number 840252
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy
Greer :
Comparison of TAK-875 With Placebo in Participants With Type 2 Diabetes
Greer :
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Greer :
Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of Glymera Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM
Greer : Mountain View Clinical Research
Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus
Greer : 1276.1.10008 Boehringer Ingelheim Investigational Site
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
Greer :
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Greer :
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Greer : Novo Nordisk Clinical Trial Call Center
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Greer : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Hodges : 1245.25.10132 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Mount Pleasant : Site 6
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
Mount Pleasant : Research Site
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Mt. Pleasant : 1245.25.10140 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Murrells Inlet : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Myrtle Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study in Patients With Type 2 Diabetes Mellitus
Myrtle Beach : 1245.25.10127 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Myrtle Beach : 1245.25.10065 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Myrtle Beach : Novo Nordisk Clinical Trial Call Center
Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine
North Myrtle Beach : North Myrtle Beach Family Practice
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
North Myrtle Beach : North Myrtle Beach Family Practice
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB)
North Myrtle Beach : 1245.25.10170 Boehringer Ingelheim Investigational Site
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.
Orangeburg : Pfizer Investigational Site
A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy
Pawleys Island : Pawleys Pediatrics And Adult Medicine
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
Pelzer : Novo Nordisk Clinical Trial Call Center
The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy
Simpsonville : Hillcrest Clinical Reseach, Llc
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
